Insulin analogues and their potential in the management of diabetes mellitus

Author(s): Bolli GB, Di Marchi RD, Park GD, Pramming S, Koivisto VA


The introduction of insulin analogues, of which insulin lispro is the prototype, marks a very important milestone in the management of patients with diabetes mellitus. It differs from regular human insulin in its quicker onset and shorter duration of action. In various clinical trials, insulin lispro was found to be superior to regular human insulin in controlling postprandial hyperglycemia without increasing the risk of hypoglycemia. It improved the quality of life of diabetic patients by providing more flexibility to meal plans. Recently, another short acting insulin analogue called insulin aspart has been tried in clinical studies with benefits similar to insulin lispro. The turn of the millennium is now witnessing the development of long acting insulin analogues like insulin glargine, which can provide continuous low-level basal insulin concentrations similar to natural settings. In this review, we discuss the potential of insulin analogues in the modern management of diabetes with emphasis on insulin lispro.

Similar Articles

Less hypoglycemia with insulin glargine in intensive insulin therapy for type 1 diabetes

Author(s): Ratner RE, Hirsch IB, Neifing JL, Garg SK, Mecca TE, et al.

Meta-analysis of the effect of insulin lispro on severe hypoglycemia in patients with type 1 diabetes

Author(s): Brunelle BL, Llewelyn J, Anderson JH Jr, Gale EA, Koivisto VA

Prevention of perinatal morbidity by tight metabolic control in gestational diabetes mellitus

Author(s): Drexel H, Bichler A, Sailer S, Breier C, Lisch HJ, et al.

Correlations of receptor binding and metabolic and mitogenic potencies of insulin analogs designed for clinical use

Author(s): Kurtzhals P, Schäffer L, Sørensen A, Kristensen C, Jonassen I, et al.

Use of insulin glargine during pregnancy in a type 1 diabetic woman

Author(s): Devlin JT, Hothersall L, Wilkis JL

Insulin glargine use during pregnancy

Author(s): Pantalone KM, Faiman C, Olansky L

Perinatal outcomes associated with the use of glargine during pregnancy

Author(s): Di Cianni G, Torlone E, Lencioni C, Bonomo M, Di Benedetto A, et al.

Perinatal outcomes in pregnancies managed with antenatal insulin glargine

Author(s): Egerman RS, Ramsey RD, Kao LW, Bringman JJ, Haerian H, et al.